SEC Filing Summary: Charles River Laboratories International, Inc.
Business Context and Reporting Period
This Form 8-K, dated November 6, 2024, reports the issuance of a press release containing financial results for the third quarter ended September 28, 2024. The filing serves as a notification of these results and incorporates the press release as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It directs readers to the attached press release for the full results and comparison.
Guidance, Outlook, and Risks
The press release referenced in this filing includes "safe harbor" language under the Private Securities Litigation Reform Act of 1995, indicating the presence of forward-looking statements. The filing notes that risks relating to the company are set forth in other documents filed with the SEC. No specific guidance or unusual items are detailed in the text of this Form 8-K.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific Q3 2024 revenue and earnings figures.
- Verify forward-looking statements and associated risk factors detailed in the press release.
- Check other SEC filings for comprehensive risk disclosures referenced in this report.
- Confirm the exact quarter end date of September 28, 2024, for accurate period comparison.